LETTER
A Novel Three-Component Synthesis
823
(12) Typical procedure under microwave-assisted conditions:
A mixture of b-naphthol (1 mmol), benzaldehyde (1 mmol)
and urea (1.5 mmol) were finely mixed together. The
reaction mixture was placed in a screw-capped vial and
irradiated for 6 min with a power of 900 W. After cooling,
the reaction mixture was washed with H2O and then
recrystallized from EtOAc–hexane (1:3) to afford the pure
product 4a (81%); mp 218–220 °C; IR (KBr): 3295, 1730,
1517 cm–1; 1H NMR (300 MHz, DMSO-d6): d = 6.19 (d,
J = 2.1 Hz, 1 H, CH), 7.24–8.00 (m, 11 H, Ar–H), 8.87 (br s,
1 H, NH); 13C NMR (75 MHz, DMSO-d6): d = 54.20,
114.50, 117.32, 123.57, 125.54, 127.42, 127.81, 128.47,
129.08, 129.32, 129.41, 130.68, 130.86, 143.34, 147.85,
149.77; MS (ESI): m/z (%) = 275 (7) [M+], 231 (100), 202
(35), 51 (24).
Acknowledgment
We gratefully acknowledge the financial support from the Research
Council of Shahid Beheshti University.
References and Notes
(1) (a) Patel, M.; McHugh, R. J. Jr.; Cordova, B. C.; Klabe, R.
M.; Erickson-Viitanen, S.; Trainor, G. L.; Ko, S. S. Bioorg.
Med. Chem. Lett. 1999, 9, 3221. (b) El-Shafei, H. A.; Badr-
Eldin, S. M. Egypt. J. Microbiol. 1994, 27, 353.
(c) Sugimoto, H.; Yonaga, M.; Karibe, N.; Limura, Y.;
Nagato, S.; Sasaki, A.; Yamanishi, Y.; Ogura, H.; Kosasa,
T.; Uchikoshi, K.; Yamatsu, K. Eur. Patent Appl. Ep 468
187, 1992; Chem. Abstr. 1992, 116, 235643. (d) Waxman,
L.; Darke, P. L. Antiviral Chem. Chemother. 2000, 11, 1.
(e) Girgis, A. S. Pharmazie 2000, 466.
(2) Latif, N.; Mishriky, N.; Assad, F. M. Aust. J. Chem. 1982,
35, 1037.
(3) Wang, Y.; Li, X.; Ding, K. Tetrahedron: Asymmetry 2002,
13, 1291.
(4) Ikeda, K.; Morimoto, T.; Sekia, M. Chem. Pharm. Bull.
1980, 1178.
(5) Szatmari, I.; Hetenyi, A.; Lazar, L.; Fulop, F. J. Heterocyclic
Chem. 2004, 41, 367.
(6) Cimarelli, C.; Palmieri, G.; Volpini, E. Can. J. Chem. 2004,
82, 1314.
(7) (a) Betti, M. Gazz. Chim. Ital. 1900, 30II, 310. (b) Betti, M.
Org. Synth., Coll. Vol. I 1941, 381.
(8) (a) Domling, A.; Ugi, I. Angew. Chem. Int. Ed. 2000, 39,
3168. (b) Ugi, I.; Domling, A. Endeavour 1994, 18, 115.
(c) Heck, S.; Domling, A. Synlett 2000, 424.
(9) (a) Shaabani, A.; Bazgir, A. Tetrahedron Lett. 2004, 45,
2575. (b) Shaabani, A.; Dabiri, M.; Bazgir, A. Dyes Pigm.
2006, 71, 68. (c) Bazgir, A. J. Chem. Res., Synop. 2006, 1.
(d) Shaabani, A.; Bazgir, A.; Teimouri, F. Tetrahedron Lett.
2003, 44, 857.
(10) (a) Shaabani, A.; Bazgir, A. Mol. Div. 2004, 8, 141.
(b) Shaabani, A.; Teimouri, M. B.; Bazgir, A.; Bijanzadeh,
H. R. Mol. Div. 2003, 6, 199. (c) Mohammad Pour-Amini,
M.; Shaabani, A.; Bazgir, A. Catal. Commun. 2006, 7, 843.
(11) Typical procedure for the preparation of 1,2-dihydro-1-
phenylnaphtho[1,2-e][1,3]oxazine-3-one (4a) under
thermal solvent-free conditions: A mixture of b-naphthol
(1 mmol), benzaldehyde (1 mmol), urea (1.5 mmol) and
PTSA (0.3 mmol) was finely mixed together. The reaction
mixture was placed in a screw-capped vial and heated at
160 °C for 1.5 h. After cooling, the reaction mixture was
washed with H2O and then recrystallized from EtOAc–
hexane (1:3) to afford the pure product 4a as a white powder
(58%).
(13) (a) Kappe, C. O. J. Org. Chem. 1997, 62, 7201. (b) Huang,
S.; Pan, Y.; Zhu, Y.; Wu, A. Org. Lett. 2005, 7, 3797.
(c) Cristau, P.; Vors, J.; Zhu, J. P. Tetrahedron Lett. 2003,
44, 5575. (d) Dondoni, A.; Massi, A.; Minghini, E.;
Bertolasi, V. Tetrahedron 2004, 60, 2311.
(14) Selected characterization data:
1,2-Dihydro-1-(4-methylphenyl)naphtho[1,2-
e][1,3]oxazine-3-one (4b): mp 166–16 °C; IR (KBr): 3230,
3139, 1717 cm–1; 1H NMR (300 MHz, DMSO-d6): d = 2.21
(s, 3 H, CH3), 6.13 (d, J = 2.4 Hz, 1 H, CH), 7.10–7.99 (m,
10 H, Ar–H), 8.81 (s, 1 H, NH); 13C NMR (75 MHz, DMSO-
d6): d = 21.06, 53.98, 114.61, 117.29, 123.56, 125.49,
127.32, 127.76, 129.05, 129.33, 129.89, 130.59, 130.85,
137.78, 140.43, 147.80, 149.81; MS (ESI): m/z (%) = 290
(10) [M+ + H], 231 (100), 202 (20).
1,2-Dihydro-1-(4-chlorophenyl)naphtho[1,2-
e][1,3]oxazine-3-one (4f): mp 208–210 °C; IR (KBr): 3224,
3146, 1734 cm–1; 1H NMR (300 MHz, DMSO-d6): d = 6.24
(s, 1 H, CH), 7.31–8.01 (m, 10 H, Ar–H), 8.91 (s, 1 H, NH);
13C NMR (75 MHz, DMSO-d6): d = 53.42, 114.02, 117.34,
123.50, 125.62, 127.91, 128.06, 129.13, 129.23, 129.37,
129.42, 130.87, 133.06, 142.22, 147.90, 149.61; MS (ESI):
m/z (%) = 309 (5) [M+], 265 (60), 231 (100), 202 (27), 115
(15).
1-{[2-Hydroxynaphthalen-1-yl](phenyl) methyl} urea
(intermediate 5): mp 190–192 °C; IR (KBr): 3463, 3406,
3347, 3219, 1664 cm–1; 1H NMR (300 MHz, CD3SOCD3):
d = 5.82 (s, 2 H, NH2, exchanges with D2O), 6.91–7.81 (m,
13 H), 9.94 (br s, 1 H, OH); 13C NMR (75 MHz,
CD3SOCD3): d = 48.56, 119.05, 120.58, 122.72, 123.27,
126.22, 126.81, 128.26, 128.69, 129.0, 129.33, 132.71,
144.77, 153.51, 159.01; MS (ESI): m/z (%): 275 (5) [M+ –
NH3], 231 (100), 202 (15), 144 (100).
Synlett 2007, No. 5, 821–823 © Thieme Stuttgart · New York